The global Rheumatoid Arthritis Market is forecast to reach USD 37.41 Billion by 2028, according to a new report by Reports and Data. Rheumatoid arthritis is an inflammatory disease that affects the joints. The condition worsens over time unless the inflammation is slowed or stopped. The disease rarely goes into remission without treatment.
Rheumatoid arthritis symptoms and progression must be controlled with the use of arthritis drugs. The optimum medical care involves Rheumatoid Arthritis and other treatments, and treatment should be started as soon as possible following diagnosis. According to statistics, every year, 41 out of every 100,000 persons are given a RA diagnosis. Women are around two to three times as likely than males to get RA. Both male and female hormones may contribute to its occurrence or prevent it.
Request Free Sample Copy @ https://www.reportsanddata.com/download-free-sample/2394
Further key findings from the report suggest
- Biopharmaceuticals are Drugs products such as proteins, including antibodies that are produced in living systems and used for diagnostic or therapeutic purposes or as dietary supplements.
- Glucocorticoids are strong anti-inflammatory steroids that can block other immune responses. These medications can relieve symptoms and may stop or slow joint damage. These Drugs can be received by injection or by pill. They can cause severe digestive tract problems. Patients with a history of liver, kidney, heart problems, or stomach ulcers, should not consume them.
- Hospital pharmacies are expected to dominate the market owing to the increase in the rheumatologist consultations in clinics and hospitals. The prolonged use of these medications can lead to Drugs resistance, which compels the patients to refer to a rheumatologist and follow guided therapies. Moreover, the number of OTC Drugs available for treatment is insufficient, which, in turn, is further propelling the growth of this segment.
- The market in Asia-Pacific is anticipated to witness high growth during the forecast period owing to the increasing healthcare expenditure. Furthermore, the low cost of manufacturing in India and China has resulted in an increase in the production facilities, which attracts pharmaceutical and biotechnological giants to the region.
Competitive Outlook of the Global Rheumatoid Arthritis Market
The globla Rheumatoid Arthritis market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Rheumatoid Arthritis market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.
Top Companies Profiled in the Report:
Amgen Inc., Celgene Corporation, Boehringer Ingelheim GmbH, Johnson Johnson, Novartis AG, AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, and Merck Co. Inc., among others.
Rheumatoid Arthritis Market Segmentation:
Drugs Class Outlook (Revenue, USD Billion; 2018-2028)
- Corticosteroids
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Analgesics
- Other Drugs Classes
Route of Administration Outlook (Revenue, USD Billion; 2018-2028)
- Oral
- Subcutaneous
- Intravenous
Sales Channel Outlook (Revenue, USD Billion; 2018-2028)
- Hospital Pharmacies
- Retail Pharmacies
- Online
Geographic Segment Covered in the Report:
The Rheumatoid Arthritis report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
- North America (USA and Canada)
- Europe (UK, Germany, France and the rest of Europe)
- Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
- Latin America (Brazil, Mexico, and the rest of Latin America)
- Middle East and Africa (GCC and rest of the Middle East and Africa)
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2394
We appreciate you reading our report. To learn more about the report and its customizable feature, please get in touch with us. Our team will make sure the report is suitable for your needs.
Get Explore Latest Research Report by Reports and Data:
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
